UF Researchers Identify New Cancer-Killing Compounds (Doctor Gator)
UF researchers have uncovered new insights into how activating the DR5 receptor can selectively kill cancer cells, bringing science closer to developing safer and more effective cancer therapies.
Tech Tuesday: University of Florida Lab Helps Patients Better Understand Neuromuscular Diseases (WCJB TV20)
In this week’s Tech Tuesday, UF Innovate spotlights the Wang Lab at the University of Florida, which is focusing on neuromuscular disease research, particularly myotonic dystrophy.
UF College of Medicine Launches Pediatric Obesity Fellowship To Tackle National Epidemic
UF’s Pediatric Obesity Fellowship Training Program is paving the way for specialized training to address the growing need for obesity prevention and treatment.
UF Health Expert Discusses COVID-19 Booster Shots
Michael Lauzardo, M.D., deputy director of UF’s Emerging Pathogens Institute and an associate professor in the UF College of Medicine’s department of medicine, talks about issues related to the third vaccine dose.
UF Health Researcher, Collaborators Discover Compounds That Might Boost Stroke Recovery
When a patient suffers a stroke, oxygen-starved brain cells begin dying within minutes. In these crucial moments, the brain produces a vital catalyst to protect itself and aid in recovery. That catalyst — an enzyme known as neurolysin — activates a cascade of chemical messengers that reduce cell damage, swelling and inflammation in the brain. Now, a University of Florida Health researcher and his collaborators at Texas Tech University and other universities have discovered two compounds that appear to make the brain-protecting enzyme even more effective.
Patients With Severe COVID-19 Twice As Likely To Require Future Hospitalizations for Other Illnesses
People who have recovered from a bout of severe COVID-19 may still have a reason for concern about their health. A new University of Florida study has found that patients who had a severe case of the disease were more than twice as likely as patients who had mild or moderate COVID-19 to need hospitalization again for health problems caused by COVID-19 complications.
UF Neurosurgery Chair Elected President of Congress of Neurological Surgeons
University of Florida neurosurgery chair Brian Hoh, M.D., MBA, has been elected the 2020-21 president of the Congress of Neurological Surgeons, one of the largest international neurosurgical societies, with over 9,800 members. Two other UF Health neurosurgeons, Daniel Hoh, M.D., and Maryam Rahman, M.D., also have been elected to leadership positions in the CNS: Daniel Hoh will serve […]
Five Questions for Michael S. Okun, M.D.
Michael S. Okun, M.D. is chair of Neurology, Adelaide Lackner professor, and executive director of the Norman Fixel Institute for Neurological Diseases at the University of Florida College of Medicine. He received his M.D. with honors from the University of Florida and, subsequently, was fellowship-trained at Emory University before establishing the movement disorders program at […]
Atsena Therapeutics Acquires Exclusive Rights to Gene Therapy for GUCY2D-Associated Leber Congenital Amaurosis
UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced that it has acquired exclusive rights to a gene therapy targeting GUCY2D-associated Leber congenital amaurosis (LCA1), a genetic eye disease that affects the retina and is a leading cause of blindness […]
UF Neurologists Create a New Image of Parkinson Disease
An outdated sketch from 1886 by Sir William Richard Gowers remains among the most used and viewed depictions of Parkinson disease, despite great advancements in the understanding of the neurological disorder. Now, UF neurologists Melissa Armstrong, M.D. and Michael S. Okun, M.D. have worked with a medical illustrator to create a new, more diverse representation of who is affected by […]